BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12892394)

  • 1. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss.
    Salmon JE; Girardi G; Holers VM
    Lupus; 2003; 12(7):535-8. PubMed ID: 12892394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.
    Holers VM; Girardi G; Mo L; Guthridge JM; Molina H; Pierangeli SS; Espinola R; Xiaowei LE; Mao D; Vialpando CG; Salmon JE
    J Exp Med; 2002 Jan; 195(2):211-20. PubMed ID: 11805148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in the antiphospholipid syndrome.
    Salmon JE; Girardi G
    Curr Dir Autoimmun; 2004; 7():133-48. PubMed ID: 14719378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement inhibition keeps mothers calm and avoids fetal rejection.
    Girardi G
    Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.
    Pierangeli SS; Girardi G; Vega-Ostertag M; Liu X; Espinola RG; Salmon J
    Arthritis Rheum; 2005 Jul; 52(7):2120-4. PubMed ID: 15986360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
    Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
    J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guilty as charged: all available evidence implicates complement's role in fetal demise.
    Girardi G
    Am J Reprod Immunol; 2008 Mar; 59(3):183-92. PubMed ID: 18275511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement in pregnancy and fetal loss.
    Girardi G; Salmon JB
    Autoimmunity; 2003 Feb; 36(1):19-26. PubMed ID: 12765467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome.
    Pierangeli SS; Vega-Ostertag M; Liu X; Girardi G
    Ann N Y Acad Sci; 2005 Jun; 1051():413-20. PubMed ID: 16126983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation.
    Salmon JE; Girardi G
    J Reprod Immunol; 2008 Jan; 77(1):51-6. PubMed ID: 17418423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
    Girardi G; Redecha P; Salmon JE
    Nat Med; 2004 Nov; 10(11):1222-6. PubMed ID: 15489858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and the antiphospholipid syndrome.
    Lim W
    Curr Opin Hematol; 2011 Sep; 18(5):361-5. PubMed ID: 21730831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss.
    Berman J; Girardi G; Salmon JE
    J Immunol; 2005 Jan; 174(1):485-90. PubMed ID: 15611274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
    Girardi G; Yarilin D; Thurman JM; Holers VM; Salmon JE
    J Exp Med; 2006 Sep; 203(9):2165-75. PubMed ID: 16923853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice.
    Ulrich V; Gelber SE; Vukelic M; Sacharidou A; Herz J; Urbanus RT; de Groot PG; Natale DR; Harihara A; Redecha P; Abrahams VM; Shaul PW; Salmon JE; Mineo C
    Arthritis Rheumatol; 2016 Mar; 68(3):730-739. PubMed ID: 26474194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation and pregnancy failure.
    Tincani A; Cavazzana I; Ziglioli T; Lojacono A; De Angelis V; Meroni P
    Clin Rev Allergy Immunol; 2010 Dec; 39(3):153-9. PubMed ID: 19936969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
    Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
    Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of complement in the antiphospholipid syndrome-associated pathology.
    Avalos I; Tsokos GC
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):141-4. PubMed ID: 19067251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study.
    Veglia M; D'Ippolito S; Marana R; Di Nicuolo F; Castellani R; Bruno V; Fiorelli A; Ria F; Maulucci G; De Spirito M; Migliara G; Scambia G; Di Simone N
    Am J Reprod Immunol; 2015 Dec; 74(6):542-52. PubMed ID: 26388133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity.
    Samarkos M; Mylona E; Kapsimali V
    Semin Arthritis Rheum; 2012 Aug; 42(1):66-9. PubMed ID: 22405029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.